September 20, 2024 Credit: Unsplash/CC0 Public DomainTwo new drugs, the first capable of slowing down the debilitating progression of Alzheimer’s disease, have become embroiled in one of the biggest medical controversies in recent years. For their defenders, the drugs lecanemab and donanemab represent the first real chance to fight the disease after decades of research—for...
